Jacobs Levy Equity Management
LCTX icon

Jacobs Levy Equity Management’s Lineage Cell Therapeutics LCTX Stock Holding History

Jacobs Levy Equity Management’s Portfolio LCTX Stock Details LCTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,033,763
Closed -$519K – 1147
2024
Q4 		$519K Buy
+1,033,763
New +$759K ﹤0.01% 810
2023
Q1 		– Sell
-202,202
Closed -$237K – 1019
2022
Q4 		$237K Sell
202,202
-55,259
-21% -$69.6K ﹤0.01% 889
2022
Q3 		$291K Buy
+257,461
New +$378K ﹤0.01% 891
2018
Q3 		– Sell
-118,687
Closed -$214K – 1035
2018
Q2 		$214K Buy
118,687
+38,876
+49% +$78.3K ﹤0.01% 947
2018
Q1 		$188K Sell
79,811
-68,819
-46% -$161K ﹤0.01% 937
2017
Q4 		$280K Sell
148,630
-13,393
-8% -$29.2K ﹤0.01% 853
2017
Q3 		$403K Buy
162,023
+30,568
+23% +$75.8K 0.01% 737
2017
Q2 		$362K Buy
+131,455
New +$367K 0.01% 740

Other funds holding LCTX

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DC
Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return
RA
Raffles Associates New York $115M AUM 35.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Comerica Bank
Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return